Yale, CTPharma announce state’s 1st research study into medical marijuana

Along with CTPharma, an in-state medical grower, they will look at whether pot pills can stop chronic pain and stress.

News 12 Staff

Nov 8, 2019, 10:45 PM

Updated 1,800 days ago

Share:

Yale has launched the state's first-ever research study into medical marijuana.
Along with CTPharma, an in-state medical grower, they will look at whether pot pills can stop chronic pain and stress.
Cori Alicea, of Bridgeport told News 12 that she was a happy, healthy mother until she developed brain cancer. After 30 surgeries, Alicea couldn't even walk due to chronic pain. She says she can stand because of medical marijuana.
“This medicine has made it so I'm able to live my daily life,” Alicea told News 12. "It makes it so I'm able to be alert. I have no more pain. I can be with my children on a regular basis."
Dr. Rajita Sinha, of Yale’s School of Medicine, says the research will look into how medical marijuana works, who it works for and what kind of doses are appropriate.
Mike Fedele, chairman of CTPharma, says the research could also help the state’s economy.
“I believe that significant biotech industry will grow right here in Connecticut because of this type of study," he says.
Connecticut started allowing this kind of study three years ago, but this is the first one that's actually been approved.
Yale is actively looking for paid volunteers to participate in the study.